Clinical trials: Refractory Immune Effector Cell-related Hemocytopenia
Refractory Immune Effector Cell-related Hemocytopenia
A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia
The purpose of this study was to evaluate the safety and efficacy of umbilical cord blood mononuclear cell in the treatment of refractory immune effector cell-related hemocytopenia by observing the efficacy related factors and…
- Trial name
- NCT06729320
- Testing
- Umbilical cord blood mononuclear cells, Conventional hematopoietic recovery therapy
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Beijing GoBroad Hospital